SCHEMBL24251587

SCHEMBL24251587

Cc1nn2c(C(C)C)c(C(=O)N3CCCC3)ccc2c1-c1c(F)cccc1F

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HPGD P15428 5/20 0.44
▸ LMNA P02545 2/20 0.41
▸ KMT2A Q03164 3/20 0.40
▸ ALDH1A1 P00352 3/20 0.39
▸ KDM4E B2RXH2 2/20 0.39
▸ USP2 O75604 1/20 0.38
▸ GLA P06280 2/20 0.38
▸ SMN1; SMN2 Q16637 2/20 0.38
▸ MEN1 O00255 2/20 0.38
▸ NPC1 O15118 1/20 0.38
▸ TSHR P16473 1/20 0.38
▸ RAB9A P51151 1/20 0.38
▸ HSD17B10 Q99714 1/20 0.38
▸ GBA1 P04062 1/20 0.36
▸ CCKBR P32239 1/20 0.35
▸ HCRTR1 O43613 1/20 0.35
▸ HCRTR2 O43614 1/20 0.35
▸ POLB P06746 1/20 0.35
▸ CPS1 P31327 1/20 0.35
▸ HTT P42858 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24251391 0.90 CYP3A4 (0.37) HPGDKMT2AALDH1A1USP2SMN1; SMN2
SCHEMBL24251380 0.89 ALOX5AP (0.39) ALDH1A1HCRTR1HCRTR2
SCHEMBL24251549 0.88 SPR (0.36) HCRTR1HCRTR2
SCHEMBL24251385 0.88 SPR (0.40) HPGDKMT2AALDH1A1KDM4ESMN1; SMN2
SCHEMBL24251498 0.86 SPR (0.41) ALDH1A1USP2TSHRHSD17B10
SCHEMBL24251578 0.85 SCD5 (0.44) SMN1; SMN2NPC1RAB9AHCRTR1HCRTR2
SCHEMBL24251538 0.85 SPR (0.42) HPGDALDH1A1KDM4EHCRTR1HCRTR2
SCHEMBL23355438 0.84 PDE4B (0.35) HPGDALDH1A1KDM4EHSD17B10
SCHEMBL24251459 0.84 SPR (0.42) HPGDLMNAKMT2AALDH1A1KDM4E
SCHEMBL23355480 0.81 KMT2A (0.37) HPGDKMT2AALDH1A1KDM4EGLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220048903-A1 Anthelminthic Heterocyclic Compounds BOEHRINGER INGELHEIM VETMEDICA GMBH (DE) 2022-02-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220048903-A1 Anthelminthic Heterocyclic Compounds SDHA, PAH, PIGS HPGD 100/4885LMNA 2182/4885KMT2A 1440/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback